These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 289864

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril.
    Zawada ET, Stinson J, Ramirez G.
    Postgrad Med; 1980 Oct; 68(4):89-92, 94-5, 98. PubMed ID: 6999479
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Maximal discrimination of renovascular from essential hypertension by the saralasin test.
    Maxwell MH, Varady P, Zawada ET, Burkhalter JF, Waks U, Marks L.
    Clin Sci Mol Med Suppl; 1978 Dec; 4():297s-299s. PubMed ID: 282071
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Saralasin infusion in renovascular and essential hypertension.
    Thien T, Hoefnagels WH.
    Neth J Med; 1980 Dec; 23(2):68-73. PubMed ID: 6990282
    [No Abstract] [Full Text] [Related]

  • 9. Detection of renovascular hypertension: saralasin test versus renin determinations.
    Marks LS, Maxwell MH, Smith RB, Cahill PJ, Kaufman JJ.
    J Urol; 1976 Oct; 116(4):406-9. PubMed ID: 1053323
    [Abstract] [Full Text] [Related]

  • 10. Saralasin in human hypertension: the early experience.
    Brunner HR, Laragh JH.
    Kidney Int Suppl; 1979 Mar; (9):S36-43. PubMed ID: 289862
    [No Abstract] [Full Text] [Related]

  • 11. Use of saralasin to detect renovascular hypertension in childhood.
    Gillespie L, Ehrlich RM, Marks LS, Maxwell MH, Kaufman JJ.
    Urology; 1980 Nov; 16(5):453-6. PubMed ID: 7003900
    [Abstract] [Full Text] [Related]

  • 12. Physiologic studies with saralasin in animals.
    Gavras H, Gavras I, Brunner HR, Liang CS.
    Kidney Int Suppl; 1979 Mar; (9):S20-8. PubMed ID: 384069
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Angiotensin blockade in postoperative paradoxical hypertension of coarctation of the aorta.
    Farrell BG, Parker FB, Poirier RA, Anderson G, Streeten DH, Blackman M.
    Surg Forum; 1979 Mar; 30():189-90. PubMed ID: 395680
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Effect of saralasin on normal blood pressure and on reno-vascular hypertension (author's transl)].
    Beckerhoff R, Vetter W, Furrer J, Nussberger J, Schmied U, Siegenthaler W.
    Dtsch Med Wochenschr; 1976 Mar 12; 101(11):398-401. PubMed ID: 1253700
    [Abstract] [Full Text] [Related]

  • 19. Reactive hyper-reninaemia to angiotensin blockade identifies renovascular hypertension.
    Case DB, Atlas SA, Laragh JH.
    Clin Sci (Lond); 1979 Dec 12; 57 Suppl 5():313s-316s. PubMed ID: 232024
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin II blockade by saralasin in the evaluation of hypertension in children.
    Favre L, Boerth RC, Braren V, Dean RH, Hollifield JW.
    Kidney Int Suppl; 1979 Mar 12; (9):S75-82. PubMed ID: 289867
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.